A Side by Side Comparison of Bruker Biotyper and VITEK MS: Utility of MALDI-TOF MS Technology for Microorganism Identification in a Public Health Reference Laboratory
Open accessThe DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Abstract
Matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS) has emerged as a rapid, highly accurate, and cost-effective method for routine identification of a wide range of microorganisms. We carried out a side by side comparative evaluation of the performance of Bruker Biotyper versus VITEK MS for identification of a large and diverse collection of microorganisms. Most difficult and/or unusual microorganisms, as well as commonly encountered microorganisms were selected, including Gram-positive and negative bacteria, mycobacteria, actinomycetes, yeasts and filamentous fungi. Six hundred forty two strains representing 159 genera and 441 species from clinical specimens previously identified at the Laboratoire de santé publique du Québec (LSPQ) by reference methods were retrospectively chosen for the study. They included 254 Gram-positive bacteria, 167 Gram-negative bacteria, 109 mycobacteria and aerobic actinomycetes and 112 yeasts and moulds. MALDI-TOF MS analyses were performed on both systems according to the manufacturer's instructions. Of the 642 strains tested, the name of the genus and / or species of 572 strains were referenced in the Bruker database while 406 were present in the VITEK MS IVD database. The Biotyper correctly identified 494 (86.4%) of the strains, while the VITEK MS correctly identified 362 (92.3%) of the strains (excluding 14 mycobacteria that were not tested). Of the 70 strains not present in the Bruker database at the species level, the Biotyper correctly identified 10 (14.3%) to the genus level and 2 (2.9%) to the complex/group level. For 52 (74.2%) strains, we obtained no identification, and an incorrect identification was given for 6 (8.6%) strains. Of the 178 strains not present in the VITEK MS IVD database at the species level (excluding 71 untested mycobacteria and actinomycetes), the VITEK MS correctly identified 12 (6.8%) of the strains each to the genus and to the complex/group level. For 97 (54.5%) strains, no identification was given and for 69 (38.7%) strains, an incorrect identification was obtained. Our study demonstrates that both systems gave a high level (above 85%) of correct identification for a wide range of microorganisms. However, VITEK MS gave more misidentification when the microorganism analysed was not present in the database, compared to Bruker Biotyper. This should be taken into account when this technology is used alone for microorganism identification in a public health laboratory, where isolates received are often difficult to identify and/or unusual microorganisms.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Finally, the clinically deployed use of wholeprotein MALDI-TOF MS for rapid identification of the species and strain of pathogenic bacteria has been adopted by thousands of hospitals and clinics worldwide 70,71 .”
From How many human proteoforms are there? (2018) · cites this paper as [71]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Amplification and direct sequencing of fungal ribosomal RNA genes for phylogenetics
White, T. J., Bruns, T., Lee, S., & Taylor, J. (1990) · PCR Protocols · doi:10.1016/b978-0-12-372180-8.50042-1 · Cited by 36,648 · cited 1×
“All microorganisms were previously identified according to LSPQ reference methods: 16S rRNA [7] or tuf gene sequencing for Gram-positive bacteria, 16S rRNA, rpoB [8] or cpn60 gene [9] sequencing for Gramnegative bacteria, conventional biochemical testing for Enterobacteriaceae [10], 16S rRNA or hsp65 gene sequencing […”
MethodPCR protocols — A guide to methods and applications
U.G. (1990) · Trends in Biochemical Sciences · doi:10.1016/0968-0004(90)90252-7 · Cited by 11,702
Glass, N. L., & Donaldson, G. C. (1995) · Applied and Environmental Microbiology · doi:10.1128/aem.61.4.1323-1330.1995 · Cited by 4,755 · cited 1×
“All microorganisms were previously identified according to LSPQ reference methods: 16S rRNA [7] or tuf gene sequencing for Gram-positive bacteria, 16S rRNA, rpoB [8] or cpn60 gene [9] sequencing for Gramnegative bacteria, conventional biochemical testing for Enterobacteriaceae [10], 16S rRNA or hsp65 gene sequencing […”
MethodKurtzman, C. P., & Robnett, C. J. (1998) · Antonie van Leeuwenhoek · doi:10.1023/a:1001761008817 · Cited by 2,353 · cited 1×
“All microorganisms were previously identified according to LSPQ reference methods: 16S rRNA [7] or tuf gene sequencing for Gram-positive bacteria, 16S rRNA, rpoB [8] or cpn60 gene [9] sequencing for Gramnegative bacteria, conventional biochemical testing for Enterobacteriaceae [10], 16S rRNA or hsp65 gene sequencing […”
MethodPhylogeny, identification and nomenclature of the genus Aspergillus
Samson, R. A., Visagie, C. M., Houbraken, J., Hong, S.-B., Hubka, V., Klaassen, C. H. W., Perrone, G., Seifert, K. A., Susca, A., Tanney, J. B., et al. (2014) · Studies in Mycology · doi:10.1016/j.simyco.2014.07.004 · Cited by 1,136 · cited 1×
“All microorganisms were previously identified according to LSPQ reference methods: 16S rRNA [7] or tuf gene sequencing for Gram-positive bacteria, 16S rRNA, rpoB [8] or cpn60 gene [9] sequencing for Gramnegative bacteria, conventional biochemical testing for Enterobacteriaceae [10], 16S rRNA or hsp65 gene sequencing […”
MethodPCR protocols — A guide to methods and applications
SELIGER, H. (1990) · Trends in Biotechnology · doi:10.1016/0167-7799(90)90215-j · Cited by 1,062
Manual of Clinical Microbiology
(2011) · Wiley eBooks · doi:10.1128/9781555816728 · Cited by 1,003
Farmer, J. J., Davis, B. R., Hickman-Brenner, F. W., McWhorter, A., Huntley-Carter, G. P., Asbury, M. A., Riddle, C., Wathen-Grady, H. G., Elias, C., & Fanning, G. R. (1985) · Journal of Clinical Microbiology · doi:10.1128/jcm.21.1.46-76.1985 · Cited by 707
van Veen, S. Q., Claas, E. C. J., & Kuijper, E. J. (2010) · Journal of Clinical Microbiology · doi:10.1128/jcm.02071-09 · Cited by 667
Bizzini, A., Durussel, C., Bille, J., Greub, G., & Prod'hom, G. (2010) · Journal of Clinical Microbiology · doi:10.1128/jcm.01794-09 · Cited by 615
Research works printed but not linked: 4
- TC Dingle, 2013, Maldi-tof mass spectrometry for microorganism identification, Clin Lab Med, 33, 589, 10.1016/j.cll.2013.03.001 · DOI · Paper page
- TE McElvania, 2014, Evaluation of the Bruker Biotyper and VITEK MS MALDI-TOF MS systems for the identification of unusual and/or difficult-to-identify microorganisms isolated from clinical specimens, Eur J Clin Microbiol Infect Dis, 33, 2163, 10.1007/s10096-014-2183-y · DOI
- E Deak, 2015, Comparison of the Vitek MS and Bruker Microflex LT MALDI-TOF MS platforms for routine identification of commonly isolated bacteria and yeast in the clinical microbiology laboratory, Diagn Microbiol Infect Dis, 81, 27, 10.1016/j.diagmicrobio.2014.09.018 · DOI
- E Deak, 2015, Comparison of the Vitek MS and Bruker Microflex LT MALDI-TOF MS platforms for routine identification of commonly isolated bacteria and yeast in the clinical microbiology laboratory, Diagn Microbiol Infect Dis, 81, 27, 10.1016/j.diagmicrobio.2014.09.018 · DOI
Cited by
Items 101–172 of 172
Czeszewska-Rosiak, G., Adamczyk, I., Ludwiczak, A., Fijałkowski, P., Fijałkowski, P., Twarużek, M., Złoch, M., Gabryś, D., Miśta, W., Tretyn, A., et al. (2025) · Heliyon · doi:10.1016/j.heliyon.2025.e42015 · Cited by 8
Yee, W.-L. S., & Drum, C. L. (2020) · Advanced Therapeutics · doi:10.1002/adtp.201900163 · Cited by 8
Chen, D., Bryden, W. A., Fenselau, C., McLoughlin, M. J., Haddaway, C. R., Devin, A. P., Caton, E. R., Bradrick, S. S., Miller, J. M., Tacheny, E. A., et al. (2022) · Journal of Proteome Research · doi:10.1021/acs.jproteome.2c00238 · Cited by 7
Sulaiman, I. M., Tang, K., Segars, K., Miranda, N., Sulaiman, N., & Simpson, S. (2021) · Archives of Microbiology · doi:10.1007/s00203-021-02465-6 · Cited by 7
Rapid Multi-Omics for Bacterial Identification Using Flow Injection–Ion Mobility–Mass Spectrometry
Hynds, H. M., Carpenter, J. M., & Hines, K. M. (2025) · Analytical Chemistry · doi:10.1021/acs.analchem.5c00417 · Cited by 9
Chen, J., Zheng, F., Sun, X., Gao, H., Lin, S., & Zeng, Y. (2021) · Medical Mycology · doi:10.1093/mmy/myab049 · Cited by 6
Sulaiman, I. M., Miranda, N., Hook, W., Mendoza, J., Kumfert, Q., Barnes, T., Sung, K., Khan, S. A., Nawaz, M. S., Banerjee, P., et al. (2023) · Journal of AOAC International · doi:10.1093/jaoacint/qsad109 · Cited by 6
Impact of systemic antimicrobial therapy on the faecal microbiome in symptomatic dairy cows
Collis, R. M., Biggs, P. J., Burgess, S. A., Midwinter, A. C., Brightwell, G., & Cookson, A. L. (2024) · PLoS ONE · doi:10.1371/journal.pone.0296290 · Cited by 6
Osta, M. E., Benoist, J., Naubourg, P., Bonacorsi, S., Messine, R., Ducoroy, P., & Allaf, B. (2024) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2023-1250 · Cited by 7
Krishna, M. S., Shenoy, P. A., Priyanka, K. S., & Vishwanath, S. (2022) · Anaerobe · doi:10.1016/j.anaerobe.2022.102536 · Cited by 6
The Mass Spectrometry Revolution in Clinical Microbiology Part 1
Weiss, Z., & Basu, S. S. (2024) · Clinics in Laboratory Medicine · doi:10.1016/j.cll.2024.10.011 · Cited by 5
Systematic review–how do we identify urinary tract infections today?
Čeprnja, M., Oros, D., Andrea, J., Jurica, Ž., Barišić, K., Šubić, J. Š., & Starčević, A. (2023) · Open Journal of Bacteriology · doi:10.17352/ojb.000023 · Cited by 5
“3 % of the strains present in the VITEK MS IVD database for a wide range of microorganisms [48].”
BackgroundMethodSharaf, P. H., Backly, R. M. E., Sherif, R. A., Zaazou, A., & Hafez, S. (2022) · BMC Oral Health · doi:10.1186/s12903-022-02562-y · Cited by 5
“The importance of such an advantage is highlighted when this technology is used alone for unusual or difficult microorganism identification [29].”
Clarke, R., Bharucha, T., Arman, B. Y., Gangadharan, B., Fernandez, L. G., Mosca, S., Lin, Q., Assche, K. V., Stokes, R., Dunachie, S. J., et al. (2024) · npj Vaccines · doi:10.1038/s41541-024-00946-5 · Cited by 6
“The speed and effectiveness of this approach has led to worldwide deployment of MALDI-MS instruments; mainly Bruker MALDI Biotyper Sirius and bioMérieux VITEK MS systems in clinicallaboratoriesforroutinemedicaltesting 40 .”
BackgroundJanvier, S., Wattijn, E., Botteldoorn, N., Spiegeleer, B. M. J. D., Deconinck, E., & Vanhee, C. (2017) · Drug Testing and Analysis · doi:10.1002/dta.2304 · Cited by 5
New Technologies for the Diagnosis of Infection
Pecora, N., & Milner, D. A. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-44585-6.00006-0 · Cited by 9
Enterococcus hirae Mitral Valve Infectious Endocarditis: A Case Report and Review of the Literature
Gaudiano, R., Trizzino, M., Torre, S., Virruso, R., Fiorino, F., Argano, V., & Cascio, A. (2023) · Antibiotics · doi:10.3390/antibiotics12081232 · Cited by 4
“Both the Bruker Biotyper and VITEK MS systems are able to correctly identify a wide range of bacteria; however, VITEK MS has a higher error rate compared to Bruker Biotyper in the case of unusual microorganisms [15], as corroborated by our case in which VITEK MS inaccurately identified the microorganism grown in the b…”
ResultTaras, M. A., Cherchi, S., Campesi, I., Margarita, V., Carboni, G., Rappelli, P., & Tonolo, G. (2024) · Diabetology · doi:10.3390/diabetology5010010 · Cited by 4
“Isolated bacteria were identified by MALDI-TOF mass spectrometry according to the “direct colony extraction technique” [21].”
Methodde Souza, Â. C., Goldani, L. Z., Roesch, E. W., Lutz, L., Barth, P. O., Sampaio, P. A. D. S., Aquino, V. R., & Pereira, D. C. (2021) · International Journal of Microbiology · doi:10.1155/2021/9364231 · Cited by 5
“, the overall identification rate for our rapid method was lower than expected (52%) [13].”
ResultRadulski, Ł., Krajewska‐Wędzina, M., Lipiec, M., & Szulowski, K. (2022) · Animals · doi:10.3390/ani12080964 · Cited by 4
“After the applied sample was dry, 1 μL of matrix was added and analyzed [23].”
MethodEl-Ashker, M. R., Monecke, S., Gwida, M., Rezk, M. M., Müller, E., Saad, T., Akinduti, P. A., & Ehricht, R. (2026) · Scientific Reports · doi:10.1038/s41598-026-40144-y · Cited by 3
A Case of Nocardia africana-Related Keratitis
Chaidaroon, W., Sawetwong, P., & Manochomphu, S. (2023) · Case Reports in Ophthalmology · doi:10.1159/000533906 · Cited by 3
“In our study, a recent technology of MALDI-TOF MS [13] was employed to identify the causal bacteria that was N. africana .”
MethodDiagnostic Stewardship in Clinical Microbiology: An Indispensable Component of Patient Care
Singhal, L., Gupta, P., & Gupta, V. (2024) · Infectious Disorders - Drug Targets · doi:10.2174/0118715265294425240607110713 · Cited by 3
Diagnosis of Systemic Fungal Diseases
Dufresne, S. F., Marr, K. A., & Shoham, S. (2019) · Springer eBooks · doi:10.1007/978-1-4939-9034-4_48 · Cited by 4
Ngene, A. C., Egbere, O. J., Onyimba, I. A., Umar, U., Ezemokwe, G. C., Gimba, N., Nnadi, N. E., & Aguiyi, J. C. (2023) · PHAGE · doi:10.1089/phage.2022.0026 · Cited by 3
New Campylobacter Lineages in New Zealand Freshwater: Pathogenesis and Public Health Implications
Cookson, A. L., Burgess, S. A., Midwinter, A. C., Marshall, J. C., Moinet, M., Rogers, L., Ahmed, F., Biggs, P. J., & Brightwell, G. (2024) · Environmental Microbiology · doi:10.1111/1462-2920.70016 · Cited by 3
“The ‘in tube formic acid extraction’ technique (Lévesque et al. 2015) was performed on two or three colonies from horse blood agar resuspended in sterile molecular biology grade water, and then identified using matrix-assisted laser desorption ionisation-time of flight (MALDI-TOF) mass spectrometry…”
InfluentialSingh, R., Gupta, P., Tiwari, K., Suvirya, S., Verma, P., & Banerjee, G. (2025) · Cureus · doi:10.7759/cureus.78344 · Cited by 4
“Consequently, Bruker's MALDI-TOF MS system is considered superior to Vitek MS for dermatophyte identification due to its extensive database and superior performance [29].”
Chun, L. Y., Dolle-Molle, L., Schneewind, O., Missiakas, D. M., Beavis, K. G., & Skondra, D. (2019) · Journal of VitreoRetinal Diseases · doi:10.1177/2474126419847635 · Cited by 3
“A score of 60% indicates species-level identification.(4) The latter 2 spots from undiluted vitreous pellet and the spots from diluted vitreous did not result in an accurate identification (“no identification”).”
BackgroundMethodOrekhov, F., & Градов, О. (2023) · Advances in transdisciplinary engineering · doi:10.3233/atde230317 · Cited by 3
Trimpin, S., Inutan, E. D., Pagnotti, V. S., Karki, S., Marshall, D. D., Hoang, K., Wang, B., Lietz, C. B., Richards, A., Yenchick, F. S., et al. (2024) · Journal of Mass Spectrometry · doi:10.1002/jms.5018 · Cited by 2
Gmyterco, V. C., Luciano, F. B., Ludwig, L. A., Evangelista, A. G., Ferreira, T., Borek, F., & de Farias, M. R. (2025) · Veterinary Dermatology · doi:10.1111/vde.13323 · Cited by 2
Detection of Foodborne Pathogens Using MALDI-TOF Mass Spectrometry
Böhme, K., Caamaño‐Antelo, S., Fernández-No, I. C., Baluja, M. Q., Barros‐Velázquez, J., Cañas, B., & Calo‐Mata, P. (2025) · Elsevier eBooks · doi:10.1016/b978-0-323-90747-7.00017-x · Cited by 2
Hu, Z., Zhang, J., Chen, Z., Jin, Z., Leng, P., Zhou, J., & Xie, X. (2018) · Brazilian Journal of Microbiology · doi:10.1007/s42770-018-0027-0 · Cited by 4
Osta, M. E., Naubourg, P., Grunewald, O., Renom, G., Ducoroy, P., & Périni, J. (2019) · International Journal of Neonatal Screening · doi:10.3390/ijns5030031 · Cited by 2
“The companies Bruker Daltonik GmbH (Bremen, Germany) and Biomérieux (Lyon, France) have respectively developed Biotyper® and Vitek-MS® software packages for facilitating and accelerating the identification of microorganisms on the basis of MALDI MS data [15,16].”
MethodPranada, A. B., Cicatka, M., Heß, C., & Karásek, J. (2024) · Journal of Clinical Microbiology · doi:10.1128/jcm.00434-24 · Cited by 2
Choi, H., Kang, M., Ko, Y., Yu, H., Kim, T. Y., Huh, H. J., Lee, N. Y., & Lee, H. (2025) · Microbiology Spectrum · doi:10.1128/spectrum.01084-25 · Cited by 2
“Other factors, such as blood culture bottle type (42, 43), database quality (44, 45), and extraction methods (39, 44, 46, 47), may also affect the spectral quality and identification rates during MALDI-TOF MS analysis.”
Davis, M. T., Canning, A. D., Midwinter, A. C., & Death, R. G. (2022) · PeerJ · doi:10.7717/peerj.13914 · Cited by 2
“flight (MALDI-TOF) mass spectrometry (Bruker, Billerica, CA, USA) using the ‘‘on slide formic acid extraction’’ method (Lévesque et al., 2015).”
MethodComparative analysis of milk bacteria by two MALDI-MS systems
Pałczyńska, J., Pryshchepa, O., Ludwiczak, A., Arendowski, A., Sibińska, E., Radtke, A., & Pomastowski, P. (2025) · Scientific Reports · doi:10.1038/s41598-025-21019-0 · Cited by 1
Cookson, A. L., Collis, R. M., Devane, M. L., Marshall, J. C., Moinet, M., Gardner, A., Rogers, L., Burgess, S. A., Biggs, P. J., & Gilpin, B. (2026) · Applied and Environmental Microbiology · doi:10.1128/aem.00242-26 · Cited by 1
“Individual isolates were stored in 1.5 mL EC broth containing 30% (wt/vol) glycerol at −80°C. Bacterial identification was performed using the matrix-assisted laser desorption ionization-time of flight (MALDI-TOF) mass spectrometry (Bruker, Billerica, CA, USA) (43) “on slide formic acid extraction” method (43) with the…”
InfluentialMagrì, C., Carolis, E. D., Ivagnes, V., Posteraro, B., & Sanguinetti, M. (2026) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-025-05386-0 · Cited by 1
A “Low-Molecular” Approach to the Identification of Microorganisms by MALDI Mass Spectrometry
Milman, B. L., Il’yasov, Y. Y., Луговкина, Н. В., Golovina, A. A., & Dmitriev, A. V. (2017) · Journal of Analytical Chemistry · doi:10.1134/s1061934817130068 · Cited by 1
Proteomics and Foodborne Pathogens
Zucko, J., Oros, D., Samarin, I. R., Diminić, J., & Starcevic, A. (2020) · Elsevier eBooks · doi:10.1016/b978-0-08-100596-5.22842-4 · Cited by 1
Pomerleau-Normandin, D., Heisz, M., & Su, M. (2018) · Relevé des maladies transmissibles au Canada · doi:10.14745/ccdr.v44i05a04f · Cited by 1
“Des études ont indiqué que l’identification erronée des microorganismes par SM MALDI-TOF semble être attribuable à l’incomplétude des bases de données de référence utilisées (2,7-26).”
Choi, J.-U., Yu, Y.-B., Kim, S., Won, S., & Kim, Y.-K. (2018) · Korean Journal of Clinical Laboratory Science · doi:10.15324/kjcls.2018.50.4.414 · Cited by 1
Laboratory Identification of Bacterial Infections
Janda, J. M. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-818731-9.00085-9 · Cited by 1
Mycobacterium : Clinical and Laboratory Characteristics of Rapidly Growing Mycobacteria
Brown‐Elliott, B. A., Harrington, S. M., Morimoto, K., & Wallace, R. J. (2023) · ClinMicroNow · doi:10.1002/9781683670438.mcm0033 · Cited by 1
Choi, J.-U., Kim, S., Hwang, S., Yu, Y.-B., Kim, S., & Kim, Y.-K. (2018) · Journal of Experimental & Biomedical Sciences/Biomedical Science Letters · doi:10.15616/bsl.2018.24.2.108
“고 찰 기존의 연구들을 통해 임상적으로 의의가 있는 GPC, GNB, 진균의 대부분은 MALDI-TOF MS 분석으로 종과 속의 수준까지 간편하고 신속하게 동정이 가능함이 현재 까지 확인되었다(Bernard et al., 2012; Levesque et al., 2015).”
MALDI-TOF Mass Spectrometry-Based Microbial Identification and Beyond
Mellmann, A., & Müthing, J. (2018) · Springer eBooks · doi:10.1007/978-3-319-33900-9_10
Neuenschwander, S. M., Miani, M. A. T., Amlang, H., Perroulaz, C., Bittel, P., Casanova, C., Droz, S., Flandrois, J., Leib, S. L., Suter‐Riniker, F., et al. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/752774
Egido, S. H. (2018) · Gredos (University of Salamanca) · doi:10.14201/gredos.139585
Progress in applications of MALDI-TOF MS technology in the diagnosis of infectious diseases
Wang, L., Zhang, C., Li, X., & Peng, J. (2021) · Scientia Sinica Vitae · doi:10.1360/ssv-2021-0317
MALDI-TOF MS application for identification of filamentous fungi
Курбатова, И. В., Rakitina, D. V., Kravchenko, E. S., Мания, Т. Р., Михайловна, А. М., & Yudin, S. M. (2022) · Hygiene and Sanitation · doi:10.47470/0016-9900-2022-101-5-562-566
Identification, Characterization and Use of Microorganisms
Smith, D., Ryan, M. J., & Buddie, A. G. (2023) · CABI eBooks · doi:10.1079/9781800622135.0003
Pyne, A., & Bhattacharya, S. (2023) · Journal of The Academy of Clinical Microbiologists · doi:10.4103/jacm.jacm_4_23
Xenophilus aerolatus isolate misidentified as Brucella spp. by MALDI-TOF MS (VITEK-MS) system
Lévesque, S., Rouleau, S. G., Bergeron, D., Brown, N., Békal, S., Lalancette, C., & Alarie, I. (2024) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2024.116543
Self-citationMycobacterium : Clinical and Laboratory Characteristics of Rapidly Growing Mycobacteria
Brown‐Elliott, B. A., Harrington, S. M., Morimoto, K., & Wallace, R. J. (2023) · ClinMicroNow · doi:10.1002/9781683674849.mcm0033
Identification of filamentous fungi with MALDI-TOF: methods and perspectives (literature review)
Kurbatova, I. V., & Rakitina, D. V. (2025) · Hygiene and Sanitation · doi:10.47470/0016-9900-2025-104-4-503-509
Induced Chronic Rhinosinusitis in Rats Leads to Secondary Changes in Sinonasal Microbiota
Barriga‐Chambi, F., Ccami‐Bernal, F., Zela‐Coila, F., Hernandez‐Caycho, M., Mares‐Cuadros, C., Salas‐Palma, M., Ballón‐Echegaray, J., & Torres, R. (2025) · Laryngoscope Investigative Otolaryngology · doi:10.1002/lio2.70187
“If the system yielded a probability lower than this threshold, the microor-ganism was classified as “not identified” [20].”
Garza-González, E., Bocanegra‐Ibarias, P., Rodríguez-Noriega, E., González-Díaz, E., Silva-Sánchez, J., Garza–Ramos, U., Contreras-Coronado-Tovar, I. F., Santos-Hernández, J. E., Gutiérrez-Bañuelos, D., Mena-Ramírez, J. P., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14131022
Garza-González, E., Bocanegra‐Ibarias, P., Rodríguez-Noriega, E., González-Díaz, E., Silva-Sánchez, J., Garza–Ramos, U., Contreras-Coronado-Tovar, I. F., Santos-Hernández, J. E., Gutiérrez-Bañuelos, D., Mena-Ramírez, J. P., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14131016
Ma, Q., Zhang, Q., Yuan, Y., Yan, W., Wang, S., Xu, J., Zhang, J., Wang, Y., & Li, Y. (2020) · Figshare · doi:10.6084/m9.figshare.13120444
Garza-González, E., Bocanegra‐Ibarias, P., Rodríguez-Noriega, E., González-Díaz, E., Silva-Sánchez, J., Garza–Ramos, U., Contreras-Coronado-Tovar, I. F., Santos-Hernández, J. E., Gutiérrez-Bañuelos, D., Mena-Ramírez, J. P., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14131025
Ma, Q., Zhang, Q., Yuan, Y., Yan, W., Wang, S., Xu, J., Zhang, J., Wang, Y., & Li, Y. (2020) · Figshare · doi:10.6084/m9.figshare.13120438
Ma, Q., Zhang, Q., Yuan, Y., Yan, W., Wang, S., Xu, J., Zhang, J., Wang, Y., & Li, Y. (2020) · Figshare · doi:10.6084/m9.figshare.13120441
Garza-González, E., Bocanegra‐Ibarias, P., Rodríguez-Noriega, E., González-Díaz, E., Silva-Sánchez, J., Garza–Ramos, U., Contreras-Coronado-Tovar, I. F., Santos-Hernández, J. E., Gutiérrez-Bañuelos, D., Mena-Ramírez, J. P., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14131019
Park, B., Suh, E., Won, E. J., Kim, T. Y., Huh, H. J., Sung, H., & Kim, M.-N. (2026) · Annals of Laboratory Medicine · doi:10.3343/alm.2025.0497
“Although comparative studies have demonstrated a high overall accuracy of MALDI-TOF MS for common yeast species [25, 26], its performance for Cryptococcus spp., particularly uncommon species, has not been comprehensively assessed across platforms.”
Etude de la diversité chimique et biologique d’endophytes de palmiers
Barthélémy, M. (2019) · theses.fr (ABES) · doi:10.70675/8a19dd89zcca5z4951z8a5fz2306ac02d91d · Cited by 1
Zorba, N. N. D., Yalçın, G. T., Tosun, M. N., & Çevik, Y. N. (2026) · AQUATIC SCIENCES AND ENGINEERING · doi:10.26650/ase.2026.1887297
Menon, A., Morelli, M. K., & Hulec, H. (2026) · Case Reports in Infectious Diseases · doi:10.1155/crdi/6760136
FELÍCIO, I. M., Vianna, E. D. F., Almeida, M. M., Abreu, J. D. O., Leão, R. S., & Marques, E. A. (2026) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2026.117624
マトリックス支援レーザー脱離イオン化飛行時間型質量分析法(MALDI-TOF MS)を応用したウマ由来細菌の同定に関する研究
Uchida, E. (n.d.) · Institutional Repositories DataBase (IRDB) · doi:10.15083/0002012015
Metadata
- Authors
- Lévesque, S., Dufresne, P. J., Soualhine, H., Domingo, M.-C., Bekal, S., Lefebvre, B., & Tremblay, C.
- Affiliations
- Institut National de Santé Publique du Québec (CA)
- Corresponding author
- Lévesque, Simon
- Venue
- PLOS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2015-12-10
- Volume
- 10
- Issue
- 12
- Pages
- e0144878
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC4689555
- OpenAlex
- W2209387386
- Cited by
- 172
- References
- 34
- Citations by year
- 2026: 7 · 2025: 12 · 2024: 15 · 2023: 20 · 2022: 17 · 2021: 20 · 2020: 16 · 2019: 16 · 2018: 22 · 2017: 19 · 2016: 6
- FWCI
- 12.87
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS ONE (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Topics
- Health Sciences › Medicine › Microbiology (medical) › Bacterial Identification and Susceptibility Testing
- Physical Sciences › Chemistry › Spectroscopy › Mass Spectrometry Techniques and Applications
- Health Sciences › Medicine › Microbiology (medical) › Infections and bacterial resistance
- Keywords
- MALDI-TOF mass spectrometry, microbial identification, Bruker Biotyper, VITEK MS, method comparison, bacterial identification, mycobacteria, actinomycetes, molds and yeasts, Gram-positive bacteria, Gram-negative bacteria, reference laboratory, clinical isolates, identification accuracy, public health microbiology
- MeSH terms
- Fungi, Gram-Negative Bacteria, Humans, Mycobacterium, Public Health, Quebec, Yeasts, Reproducibility of Results, Bacterial Typing Techniques, Mycological Typing Techniques, Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization, Clinical Laboratory Techniques, Actinobacteria, Clinical Laboratory Services
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.